Stay updated on Effect of Nintedanib on ECM Biomarkers in IPF Clinical Trial
Sign up to get notified when there's something new on the Effect of Nintedanib on ECM Biomarkers in IPF Clinical Trial page.

Latest updates to the Effect of Nintedanib on ECM Biomarkers in IPF Clinical Trial page
- Check7 days agoChange DetectedThe page now shows a new site revision, v3.6.2, replacing the previous v3.6.0, indicating a minor platform update. This appears in the site metadata/footer and does not modify the study information displayed.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedEnrollment status updated to indicate recruitment has ended. The page adds new help sections and slightly updates header text and version labeling.SummaryDifference0.2%

- Check29 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5, indicating a new version of the page. This change reflects an updated record version rather than changes to study content.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page now shows Revision: v3.5.4, indicating a newer build of the page. The previous Revision: v3.5.3 tag has been removed.SummaryDifference0.0%

- Check72 days agoChange DetectedThe page content adds references in the footer area (including a “resources” section for related topics) and updates the site revision/version label. The previous revision label (v3.5.2) was replaced with the newer one (v3.5.3).SummaryDifference0.1%

- Check79 days agoChange DetectedAdded Revision: v3.5.2; Removed Revision: v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Effect of Nintedanib on ECM Biomarkers in IPF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Effect of Nintedanib on ECM Biomarkers in IPF Clinical Trial page.